The study goal is to risk stratify pediatric (Acute Respiratory Distress Syndrome) ARDS patients and to identify sub-phenotypes with shared biology in order to appropriately target therapies in future trials.
Dr. Nadir Yehya is interested in all aspects of mechanical ventilation and respiratory failure in children, including pre-clinical models, ventilator-induced lung injury, and acute respiratory distress syndrome.
